Every peptide question, answered.
ChatPEP is your AI research assistant. Answers grounded in 200M+ peer-reviewed papers, tailored to your goals.
Your expert peptide research assistant.
For the math, the morning after, and everything in between.
5mg vial, 2ml of water. How many units is 250mcg?
The number, the doses left in the vial, and the work shown.
Ask this
Week 3 on semaglutide. Is this nausea normal?
Yes, and it usually passes. The trial data explains why.
Ask this
Does BPC-157 actually do anything for tendons?
Here's what the studies found, sorted by how much weight they carry.
Ask this
Check your math.
Vial, water, dose. ChatPEP runs the numbers and shows the work, so the one mistake that matters gets caught on screen.
- Concentration
- 25 mcg per unit
- Doses per vial
- 20
250 mcg = 10 units · 0.1 ml
This information is for research only. Not intended for human use.
Signed in, the numbers travel with the question, and every figure you state gets checked against the math before ChatPEP answers.
Ask what's normal.
Queasy after a first dose, an itchy welt, a racing heart an hour later. ChatPEP tells you what the studies report, how often, and when it's worth a call.
“Is it normal to feel nauseated on my first shot of tirzepatide?”
ChatPEP
Yes, and it is the most reported effect in the trials. Nausea is strongest around the first dose and each escalation, because the slowing of gastric emptying is greatest at the start and eases over time.
In a 24-week real-world study on a low starting dose, 12% reported nausea and 25% constipation. It usually settles within the first weeks.
Mild queasiness, or actual vomiting?
You're coming up on your first dose increase.
Here's what the escalation data says about nausea at the next step, and the signs that usually mean holding for another week.
Pulse follows up on Frontier. Memory keeps the thread on every plan.
Ask the same question.
Get a real answer.
The difference is what comes back.
“Does BPC-157 actually work for tendon repair?”
A general AI assistant
I can't provide specific medical or dosing advice for BPC-157. It isn't FDA-approved for human use and is classified as a research chemical. Please consult a healthcare professional.
ChatPEP
The tendon evidence is strong, and it's preclinical. Rat models consistently report improved tendon and ligament healing, with better functional and biomechanical outcomes
The leading mechanism: BPC-157 upregulates growth hormone receptor expression in tendon fibroblasts
Human evidence stays preliminary. What exists is small and uncontrolled, and no completed Phase II/III efficacy program supports clinical use today.
Designed to keep you safe.
Every question is checked against your biometrics, because the interaction that matters is the one you'd never think to ask about.
Safety Alert
Semaglutide + Insulin
Taking semaglutide with insulin may increase your risk of hypoglycemia. Please consult with your healthcare provider.
PEP 2.0
The world's first AI model built for peptide research.
Say it once.
Mention a condition, a medication, or a goal one time, and ChatPEP carries it into every conversation after. You never explain yourself twice.
Tuesday
The next week
Since you're on levothyroxine, here's how the research approaches that combination first…
On every plan, from your first message.
Try it freeResearch that comes to you.
Pulse keeps watch between conversations and checks in at the moments that matter: week six of a course, a dose change, new research on a compound you run.
Your GHK-Cu course is wrapping up
You're at week 6. Here's what the research says about course length, and what's worth reassessing before you decide on the next one.
You moved up a dose this week
Nausea clusters around each escalation in the trials. Here's what they report about the first week at a new step.
Pulse follows up on Frontier.
See plans
Don't take peptides blindly.
Going in without answers is guessing with your health. ChatPEP grounds every answer in the research and weighs it against your biometrics.
Ask before you start